Form 4: Labcorp CEO Reports Stock Sale and RSU Vesting

Labcorp's President and CEO, Adam H. Schechter, reported a sale of common stock and the vesting and conversion of restricted stock units.

Summary

• Adam H. Schechter, President & CEO and Director of Labcorp Holdings Inc. (LH), reported transactions occurring on February 11, 2026.
• Sold 5,273 shares of common stock at a price of $284.38 per share, pursuant to a Rule 10b5-1 plan.
• Acquired 3,656 shares of common stock through the vesting of Restricted Stock Units (RSUs).
• Disposed of 1,521 shares of common stock at $289.89 per share to satisfy tax withholding obligations related to the RSU vesting.
• Following these transactions, Schechter beneficially owns 89,478 shares of common stock.
• Also holds 22,214 Restricted Stock Units, with the vested portion being part of a grant that vests in three equal annual installments beginning on February 11, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While there's a sale of shares, it's under a 10b5-1 plan, and the CEO also acquired shares through RSU vesting, which is a standard part of executive compensation.

Positives

• The vesting of Restricted Stock Units indicates ongoing compensation and retention of the CEO, aligning his interests with long-term company performance.

Negatives

• The sale of 5,273 shares by the CEO, even if pre-planned under a Rule 10b5-1 plan, results in a net reduction of his direct common stock ownership after accounting for RSU vesting and tax withholding.

Future Outlook

The filing indicates future vesting of remaining Restricted Stock Units in two more equal annual installments after February 11, 2026, suggesting continued long-term incentive alignment for the CEO.

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales, are routinely monitored by investors for insights into management's perception of future company performance. While a Rule 10b5-1 plan indicates a pre-scheduled transaction, the net reduction in direct share ownership by a key executive like a CEO can sometimes be viewed with caution, even if partially offset by RSU holdings.

Stakeholder Impact

• Shareholders: May observe the CEO's net change in direct ownership, which is slightly reduced after the reported transactions, though partially offset by RSU holdings.

Next Steps

• Future vesting of remaining Restricted Stock Units in two more equal annual installments after February 11, 2026.

Key Dates

Recommendation

The filing details routine insider transactions, including a pre-planned stock sale and RSU vesting, which are typical for executive compensation. These transactions do not provide new fundamental information about Labcorp's operational performance or strategic direction that would warrant a change in investment recommendation. Investors should hold and continue to monitor company fundamentals.

Keywords

Labcorp Holdings Inc., LH, Adam H. Schechter, Insider Trading, Form 4, Stock Sale, Restricted Stock Units, CEO, Director, Rule 10b5-1